Novavax, Inc. (NVAX)
9.755
-0.14
(-1.46%)
USD |
NASDAQ |
Jan 22, 16:00
9.75
0.00 (0.00%)
After-Hours: 16:47
Novavax Research and Development Expense (Annual): 388.77M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Pfizer Inc. | 10.74B |
| Moderna, Inc. | 4.354B |
| Merck & Co., Inc. | 15.79B |
| ANI Pharmaceuticals, Inc. | 44.58M |
| Arcturus Therapeutics Holdings, Inc. | 124.69M |